TGF-beta: a link between immunosuppression, nephrotoxicity, and CsA.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Transplantation Proceedings

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9636380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine.

  1997cited by this paper
• Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

  1996cited by this paper
• Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

  1996cited by this paper
• Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression.

  1996cited by this paper
• Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.

  1996cited by this paper
• Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney.

  1995cited by this paper
• CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS

  1995cited by this paper
• Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes.

  1995cited by this paper
• Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity.

  1995cited by this paper
• Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.

  1994cited by this paper
• Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.

  1994cited by this paper
• Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA.

  1994cited by this paper
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.

  1994cited by this paper
• Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells.

  1994cited by this paper
• Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits.

  1993cited by this paper
• Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

  1993cited by this paper
• Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

  1993cited by this paper
• Immunohistochemical localization of bone morphogenetic protein (BMP) in calcifying fibrous epulis.

  1993cited by this paper
• Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.

  1991cited by this paper
• Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex.

  1991cited by this paper
• Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma.

  1990cited by this paper
• The effect of transforming growth factor-beta on mouse mesangial cell proliferation.

  1989cited by this paper
• Further studies of the role of transforming growth factor-beta in human B cell function.

  1989cited by this paper
• Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.

  1988cited by this paper
• The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cells

  1988cited by this paper
• Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

  1988cited by this paper
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

  1987cited by this paper
• Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

  1986cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

  1986cited by this paper
• Inhibition of in vitro anti-DNA B-cell responses by cyclosporine.

  1985cited by this paper
• Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

  1984cited by this paper
• Selective suppression of an early step in human B cell activation by cyclosporin A

  1983cited by this paper
• Inhibition of T‐Cell Activity by Cyclosporin A

  1982cited by this paper
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

  1981cited by this paper

• The Possible Potential Therapeutic Targets for Drug Induced Gingival Overgrowth

  2013cites this paper
• Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy.

  2008cites this paper
• Impact of Cyclosporine A on Magnesium Homeostasis: Clinical Observation in Lung Transplant Recipients and Experimental Study in Mice

  2008cites this paper
• Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model

  2008cites this paper
• Impact of TGFbeta1 gene polymorphisms on late renal function in pediatric heart transplantation.

  2005cites this paper
• Transforming growth factor-β1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors

  2004cites this paper
• Plasma TGF-beta1 as a risk factor for gingival overgrowth.

  2004cites this paper
• Anti–Transforming Growth Factor Antibody at Low but Not High Doses Limits Cyclosporine-Mediated Nephrotoxicity Without Altering Rat Cardiac Allograft Survival: Potential of Therapeutic Applications

  2004cites this paper
• The effect of novel immunosuppressants on extracellular matrix remodelling and the expression of fibrosis associated genes in an experimental model of allograft vasculopathy

  2003cites this paper
• Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells.

  2003cites this paper
• Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.

  2002cites this paper
• Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.

  2002cites this paper
• Prostaglandin E(1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells.

  2001cites this paper
• The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.

  2001cites this paper
• In Vitro and In Vivo Transfection of p21 Gene Enhances Cyclosporin A-Mediated Inhibition of Lymphocyte Proliferation

  2000cites this paper
• The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth.

  2000cites this paper
• MATRIX ACCUMULATION IN MESANGIAL CELLS EXPOSED TO CYCLOSPORINE A REQUIRES A PERMISSIVE GENETIC BACKGROUND

  2000cites this paper
• The role of transforming growth factor-beta in transplant rejection.

  1999cites this paper
• Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.

  1999cites this paper
• TGF-beta gene polymorphism does not influence the rise in creatinine following cardiac transplantation.

  1999cites this paper
• Cyclosporine induces the expression of the cyclin inhibitor p21.

  1999cites this paper
• Transforming growth factor-beta and the dark side of cyclosporine.

  1999cites this paper
• An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs.

  1998cites this paper